Clinical trials: Wet AMD
Wet AMD
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
To obtain a genotypic analysis of patients with chronic exudative age-related macular degeneration noted to have subretinal or intraretinal edema despite continuous monthly Anti-VEGF therapy.
- Trial name
- NCT01310686
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- West Coast Retina Medical Group, Inc.
Age-Related Macular Degeneration
Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration
Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration
- Trial name
- NCT05757674
- Testing
- Sample examination
- Where
- 2 sites in Greece
- Volunteers
- 130 people, healthy volunteers welcome
- Sponsor
- University of Ioannina
Wet AMD
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
The purpose of this study is to determine whether people who have received intermittent anti-VEGF therapy have an improvement in vision after being switched to monthly injections of Lucentis.
- Trial name
- NCT00804934
- Testing
- Lucentis
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Retina Institute of Hawaii